205 related articles for article (PubMed ID: 26559973)
21. Limited compatibility of polymerase subunit interactions in influenza A and B viruses.
Wunderlich K; Juozapaitis M; Mänz B; Mayer D; Götz V; Zöhner A; Wolff T; Schwemmle M; Martin A
J Biol Chem; 2010 May; 285(22):16704-12. PubMed ID: 20363752
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the RNA-dependent RNA polymerase from influenza C virus.
Hengrung N; El Omari K; Serna Martin I; Vreede FT; Cusack S; Rambo RP; Vonrhein C; Bricogne G; Stuart DI; Grimes JM; Fodor E
Nature; 2015 Nov; 527(7576):114-7. PubMed ID: 26503046
[TBL] [Abstract][Full Text] [Related]
23. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.
Fodor E; Crow M; Mingay LJ; Deng T; Sharps J; Fechter P; Brownlee GG
J Virol; 2002 Sep; 76(18):8989-9001. PubMed ID: 12186883
[TBL] [Abstract][Full Text] [Related]
24. Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase.
Honda A; Mizumoto K; Ishihama A
Genes Cells; 1999 Aug; 4(8):475-85. PubMed ID: 10526235
[TBL] [Abstract][Full Text] [Related]
25. New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.
Pautus S; Sehr P; Lewis J; Fortuné A; Wolkerstorfer A; Szolar O; Guilligay D; Lunardi T; Décout JL; Cusack S
J Med Chem; 2013 Nov; 56(21):8915-30. PubMed ID: 24134208
[TBL] [Abstract][Full Text] [Related]
26. Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding.
Hara K; Schmidt FI; Crow M; Brownlee GG
J Virol; 2006 Aug; 80(16):7789-98. PubMed ID: 16873236
[TBL] [Abstract][Full Text] [Related]
27. Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding.
Fechter P; Mingay L; Sharps J; Chambers A; Fodor E; Brownlee GG
J Biol Chem; 2003 May; 278(22):20381-8. PubMed ID: 12646557
[TBL] [Abstract][Full Text] [Related]
28. Crystallization and X-ray crystallographic analysis of the cap-binding domain of influenza A virus H1N1 polymerase subunit PB2.
Liu Y; Meng G; Luo M; Zheng X
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Mar; 69(Pt 3):280-3. PubMed ID: 23519804
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Type-Specific Promoter Element That Differentiates between Influenza A and B Viruses.
Gao S; Zhang W; Lu C; Cao M; Cen S; Peng Y; Deng T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534045
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of influenza A virus replication by influenza B virus nucleoprotein: an insight into interference between influenza A and B viruses.
Wanitchang A; Narkpuk J; Jaru-ampornpan P; Jengarn J; Jongkaewwattana A
Virology; 2012 Oct; 432(1):194-203. PubMed ID: 22770925
[TBL] [Abstract][Full Text] [Related]
31. Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme.
Shi L; Summers DF; Peng Q; Galarz JM
Virology; 1995 Apr; 208(1):38-47. PubMed ID: 11831724
[TBL] [Abstract][Full Text] [Related]
32. Recognition of mRNA cap structures by viral and cellular proteins.
Fechter P; Brownlee GG
J Gen Virol; 2005 May; 86(Pt 5):1239-1249. PubMed ID: 15831934
[TBL] [Abstract][Full Text] [Related]
33. Biochemical characterization of avian influenza viral polymerase containing PA or PB2 subunit from human influenza A virus.
Pham PTV; Turan K; Nagata K; Kawaguchi A
Microbes Infect; 2018; 20(6):353-359. PubMed ID: 29729434
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus - A single center retrospective observational study.
Cohen R; Babushkin F; Geller K; Finn T
PLoS One; 2019; 14(3):e0214517. PubMed ID: 30921408
[TBL] [Abstract][Full Text] [Related]
35. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
Hatakeyama D
Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
[TBL] [Abstract][Full Text] [Related]
36. The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.
Stevaert A; Naesens L
Med Res Rev; 2016 Nov; 36(6):1127-1173. PubMed ID: 27569399
[TBL] [Abstract][Full Text] [Related]
37. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into reptarenavirus cap-snatching machinery.
Rosenthal M; Gogrefe N; Vogel D; Reguera J; Rauschenberger B; Cusack S; Günther S; Reindl S
PLoS Pathog; 2017 May; 13(5):e1006400. PubMed ID: 28505175
[TBL] [Abstract][Full Text] [Related]
39. Structure of influenza A polymerase bound to the viral RNA promoter.
Pflug A; Guilligay D; Reich S; Cusack S
Nature; 2014 Dec; 516(7531):355-60. PubMed ID: 25409142
[TBL] [Abstract][Full Text] [Related]
40. Two mutations in the C-terminal domain of influenza virus RNA polymerase PB2 enhance transcription by enhancing cap-1 RNA binding activity.
Zhang S; Wang Q; Wang J; Mizumoto K; Toyoda T
Biochim Biophys Acta; 2012 Jan; 1819(1):78-83. PubMed ID: 22146492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
